The largest database of trusted experimental protocols
> Disorders > Disease or Syndrome > Parainfluenza

Parainfluenza

Parainfluenza is a group of respiratory viruses that commonly infect the upper and lower respiratory tracts.
These viruses belong to the Paramyxoviridae family and are a leading cause of respiratory illness, especially in young children.
Parainfluenza viruses can cause a range of symptoms, including cough, congestion, fever, and in some cases, more severe conditions like pneumonia or croup.
Accurate identification and understanding of optimal research protocols are essential for advancing studies on Parainfluenza and developing effective treatments.
PubCompare.ai is an AI-powered tool that can help locate the best Parainfluenza research protocols from literature, preprints, and patents, ensuring reproducible and acurate findings to support your studies.

Most cited protocols related to «Parainfluenza»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2020
Adenovirus Infections Adrenal Cortex Hormones Antibiotics Bacteria Biological Assay Blood Bronchi Bronchoalveolar Lavage Fluid Complete Blood Count COVID 19 Creatine Kinase Electrolytes Feces Genes, env Influenza Influenza in Birds isolation Kidney Lactate Dehydrogenase Liver Mechanical Ventilation Methylprednisolone Middle East Respiratory Syndrome Coronavirus Nasal Cannula Nose Oligonucleotide Primers Oseltamivir Oxygen Parainfluenza Pathogenicity Patients Pharynx Physical Examination Physicians Pneumonia Real-Time Polymerase Chain Reaction Respiratory Rate Respiratory Syncytial Virus Respiratory System SARS-CoV-2 Serum Severe acute respiratory syndrome-related coronavirus Sputum Tests, Blood Coagulation Tests, Diagnostic Therapeutics Treatment Protocols Virus Virus Release

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2020
Adenovirus Infections Bacteria Chest Chinese Fungi Influenza A virus Influenza B virus Influenza in Birds Middle East Respiratory Syndrome Coronavirus Parainfluenza Patients Pharynx Physicians Radiography, Thoracic Real-Time Polymerase Chain Reaction Respiratory Rate Respiratory Syncytial Virus Respiratory System Reverse Transcriptase Polymerase Chain Reaction SARS-CoV-2 Severe acute respiratory syndrome-related coronavirus Virus

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2009
Adenovirus Infections cDNA Library Communicable Diseases Coronavirus Homo sapiens Human Metapneumovirus Human respiratory syncytial virus Influenza Measles Parainfluenza Respiration Disorders Rhinovirus Severe Acute Respiratory Syndrome Virus

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2008
Biological Assay Bovine Viral Diarrhea Viruses Cattle Coronavirus Cross Reactions Feces Herpesvirus 1, Bovine Nose Nucleic Acids Parainfluenza Pathogenicity Real-Time Polymerase Chain Reaction Respiration Disorders Respiratory Syncytial Virus, Bovine Rotavirus Ruminants Scheuermann's Disease Sterility, Reproductive Technique, Dilution Virus Vision
RMA is a new high-throughput, multiplex PCR-microsphere flow cytometry assay system for comprehensive detection of common respiratory viruses including rhinoviruses (HRV), enteroviruses, respiratory syncytial viruses (RSV), parainfluenza viruses, influenza viruses, metapneumoviruses, adenoviruses and coronaviruses. Details of the RMA assay have been previously described [33] (link). The output signal is expressed as MFI (median fluorescence intensity), and samples with an average signal >6 standard deviations of average negative control signals (typically 400 to 500 MFI) are regarded as positive. The RMA is capable of distinguishing closely related HRV and enteroviruses [33] (link).
Full text: Click here
Publication 2007
Adenoviruses Biological Assay Coronavirus Enterovirus Flow Cytometry Fluorescence Metapneumovirus Microspheres Multiplex Polymerase Chain Reaction Orthomyxoviridae Parainfluenza Respiratory Syncytial Virus Respiratory System Rhinovirus Virus

Most recents protocols related to «Parainfluenza»

From 4 healthy experimental Beagle dogs (Table 1, one female, three male, age: 5 – 9 years) of the Faculty of Veterinary Medicine (Leipzig University, Leipzig, Germany), venous blood was taken by venipuncture of the vena cephalica antebrachii into heparinized vacutainer tubes (BD Vacutainer®, 10 ml, Li-Heparin 17 IU/ml Becton Dickinson, Heidelberg, Germany). All dogs received routine vaccinations against canine distemper, rabies, canine infectious hepatitis, parvovirus infection, parainfluenza, and leptospirosis. The study was authorized by the Saxony State Office (Landesdirektion Sachsen) in Leipzig, Germany (approval number: DD24.1-5131/444/30).
Full text: Click here
Publication 2023
Canine Distemper Canis familiaris Faculty Females Heparin Hydrophobia Infections, Parvovirus Infectious Canine Hepatitis Leptospirosis Males Parainfluenza Phlebotomy Vaccination Veins
A retrospective ecologic cohort analysis drawing on data from July 1, 2011, to June 30, 2022, in independent, unlinked datasets to visualize and define associations between hepatitis diagnoses in children and virus activity.
The Victorian Agency for Health Information collates, analyses and shares health data from public hospitals across the Australian state of Victoria (population 6.5 million).7 Data are collated under one of 2 main datasets: the Victorian Emergency Minimum Dataset captures emergency department presentations in Victorian public hospitals, and the Victorian Admitted Episodes Dataset (VAED) contains data from Victorian public hospital admissions. Data are stored by ICD-10-AM codes and hepatitis cases were identified using a broad set of relevant codes. We extracted fields related to date of presentation; age (5-year bands); patient area of residence, aggregated to statistical area level 3 (SA3). (“SA3s are designed to provide a regional breakdown of Australia. They generally have a population of between 30,000 and 130,000 people. In regional areas, SA3s represent the area serviced by regional cities that have a population >20,000 people. In the major cities, SA3s represent the area serviced by a major transport and commercial hub. They often closely align to large urban local government areas (eg, Gladstone, Geelong). In outer regional and remote areas, SA3s represent areas that are widely recognized as having a distinct identity and similar social and economic characteristics.”8 )
Monash Health (MH), based in southeast Melbourne, is the largest health network in Victoria, with >210,000 annual pediatric and adult presentations across 3 emergency departments.9 The Royal Children’s Hospital Melbourne (RCH) is the largest children’s hospital in Victoria, with care extending to children from Tasmania, New South Wales and other Australian states. RCH has almost 55,000 admissions annually, with various other non-admission services.1 We obtained respiratory multiplex polymerase chain reaction (PCR) test results during our study period from the 2 pediatric tertiary care hospitals in Victoria. PCR assays reported results for the following viruses: adenovirus, influenza A and B, parainfluenza 1, 2, 3 and 4, SARS-CoV-2, human metapneumovirus (hMPV), respiratory syncytial virus (RSV), parechovirus and picornavirus using commercial multiplex respiratory PCR panels (AusDiagnostics, Syndey, Australia). Data fields included date of test, patient area of residence aggregated to SA3 and PCR test result.
Our inclusion criteria were all respiratory multiplex PCR assays performed at MH and the Royal Children’s Hospital for patients of all ages with a Victorian residential SA3. All hepatitis presentations were included from the VAED, and Victorian Emergency Minimum Dataset between July 1, 2011, and June 30, 2022, if the patient was <19 years old on the day of presentation. Hepatitis A-E cases were excluded, as these cases had an identified viral etiology. Patient records were not available for analysis to ensure patient de-identification.
Publication 2023
Adenoviruses Adult Biological Assay Catabolism Child Diagnosis Emergencies Hepatitis A Hepatitis E Human Metapneumovirus Influenza Inpatient Multiplex Polymerase Chain Reaction Parainfluenza Parechovirus Patients Picornaviridae Polymerase Chain Reaction Respiratory Function Tests Respiratory Rate Respiratory Syncytial Virus SARS-CoV-2 Virus Virus Physiological Phenomena
Each specimen was first screened for RSV by means of the Resp-4-Plex kit (Abbott Molecular Inc., Des Plaines, IL, USA) used with the fully automated Alinity m System (Abbott Molecular Inc., Des Plaines, IL, USA) and according to the manufacturer’s instructions. This kit is a multiplex real-time reverse transcription polymerase chain reaction (RT-PCR) for the qualitative detection and differentiation of RNA from SARS-CoV-2, RSV, influenza A and B viruses. According to the manufacturer, the limit of detection is 0.300 and 0.100 median tissue culture infectious dose (TCID50)/ml for RSV-A and RSV-B, respectively [30 ].
To discern RSV subgroup and detect the presence of other respiratory pathogens, samples positive for RSV were further tested by means of the Allplex Respiratory Panel (RP) assays (Seegene Inc.; Seoul, Republic of Korea) according to the manufacturer’s instructions. Briefly, nucleic acids were first extracted using the STARMag Universal Cartridge Kit (Seegene Inc.; Seoul, Republic of Korea) on the automated Nimbus IVD (Seegene Inc.; Seoul, Republic of Korea) platform. For this purpose, 200 µl of each specimen was extracted and eluted with 100 µl of elution buffer and set up for RT-PCR. RT-PCR was then performed on a CFX96 instrument (Bio-Rad Laboratories, Inc; Hercules, CA, USA) with the Allplex RPs 1–4 kits. These four panels are able to detect the most common respiratory pathogens - both viruses [RP 1: RSV-A, RSV-B, influenza viruses A, A(H1N1), A(H1N1)pdm09, A(H3N2) and B; RP 2: adenovirus (AdV), enterovirus (EV), metapneumovirus (MPV), parainfluenza (PIV) viruses 1–4; RP 3: bocaviruses (BoV) 1–4, coronaviruses (CoV) 229E, NL63, OC43, rhinovirus (RV)] and bacteria [RP 4: Streptococcus pneumoniae (SP), Bordetella parapertussis (BPP), Bordetella pertussis (BP), Chlamydophila pneumoniae (CP), Haemophilus influenzae (HI), Legionella pneumophila (LP), Mycoplasma pneumoniae (MP)]. For each RT-PCR, 8 µl of the extracted nucleic acid in a final volume of 25 µl was used. The diagnostic accuracy of this assay in detecting RSV-A and RSV-B is 100% [31 (link)].
Samples showing cycle threshold (Ct) values < 40 in at least one assay were deemed positive. Ct values were used as a proxy measure of viral load: lower Ct values indicate higher viral load.
Full text: Click here
Publication 2023
Adenoviruses Bacteria Biological Assay Bocavirus Bordetella parapertussis Bordetella pertussis Buffers Chlamydophila pneumoniae Coronavirus 229E, Human Diagnosis Enterovirus Haemophilus influenzae Herpesvirus 1, Cercopithecine Infection Influenza Legionella pneumophila Metapneumovirus Mycoplasma pneumoniae Nucleic Acids Orthomyxoviridae Parainfluenza Pathogenicity Real-Time Polymerase Chain Reaction Respiratory Rate Reverse Transcriptase Polymerase Chain Reaction Reverse Transcription Rhinovirus SARS-CoV-2 Streptococcus pneumoniae Tissues Virus

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Adenovirus Infections Coronavirus Infections Enterovirus Infections Homo sapiens Human Metapneumovirus Human respiratory syncytial virus Infection Influenza Parainfluenza Pathogenicity Physicians Respiratory Rate Respiratory Tract Infections Rhinovirus Strains Virus
To determine the analytical sensitivity of the One-Step LAMP assay, tenfold serial dilutions from 1× 106 to 1 × 10− 3 copies of the RNA standard strain of SARS-CoV-2 were prepared in 1X HBSS (Gibco, 14,025–092) using the qPCR. The copy numbers of the RNA standard in each dilution were calculated using the qPCR according to Ji and colleagues’ method [38 (link)]. The accuracy of the analytical sensitivity results was confirmed by repeating the tests three times. Also, to ensure the results obtained for the analytical sensitivity test and to avoid possible visual error in the reaction tubes’ color examination, the reaction product was electrophoresed on a 1.5% agarose gel and evaluated under UV in the gel documentation. A set of 15 positive and 10 negative clinical samples previously tested by RT-qPCR were also selected to determine the clinical sensitivity of the One-Step LAMP assay using the optimized One-Step LAMP protocol.
The analytical specificity of the One-Step LAMP assay was examined by detecting the various templates, including Influenza A virus, Influenza B virus, Respiratory syncytial virus, Adenovirus, Parainfluenza virus, Klebsiella pneumoniae, Streptococcus pneumoniae, Haemophilus influenza, Pseudomonas aeruginosa, Legionella pneumophila, Bordetella Pertussis, Staphylococcus aureus, Mycoplasma pneumoniae, and Chlamydia pneumoniae as well as human positive samples of HIV ، HBV ، HCV ، EBV ، CMV ، HPV, and HSV1, and 2., and synthetic nucleic acid sequences prepared as a gift from Infectious Disease Control Center, Ministry of Health and Medical Education, Tehran, Iran.
Full text: Click here
Publication 2023
Adenovirus Infections Base Sequence Bordetella pertussis Chlamydophila pneumoniae Communicable Disease Control Education, Medical Haemophilus influenzae Hemoglobin, Sickle HIV Seropositivity Homo sapiens Human Herpesvirus 1 Hypersensitivity Influenza A virus Influenza B virus Klebsiella pneumoniae LAMP assay Legionella pneumophila Mycoplasma pneumoniae Parainfluenza Pseudomonas aeruginosa Respiratory Syncytial Virus SARS-CoV-2 Sepharose Staphylococcus aureus Infection Strains Streptococcus pneumoniae Technique, Dilution Virus

Top products related to «Parainfluenza»

Sourced in Germany, United States, United Kingdom, France, Spain, Japan, China, Netherlands, Italy, Australia, Canada, Switzerland, Belgium
The QIAamp Viral RNA Mini Kit is a laboratory equipment designed for the extraction and purification of viral RNA from various sample types. It utilizes a silica-based membrane technology to efficiently capture and isolate viral RNA, which can then be used for downstream applications such as RT-PCR analysis.
Sourced in Cameroon
The Anyplex II RV16 Detection Kit is a real-time PCR-based diagnostic assay designed to detect and identify 16 common respiratory viruses, including influenza A/B, respiratory syncytial virus A/B, and human rhinovirus, among others. The kit provides a rapid and sensitive method for the simultaneous detection of these respiratory pathogens.
Sourced in Germany, United States, France, United Kingdom, Netherlands, Spain, Japan, China, Italy, Canada, Switzerland, Australia, Sweden, India, Belgium, Brazil, Denmark
The QIAamp DNA Mini Kit is a laboratory equipment product designed for the purification of genomic DNA from a variety of sample types. It utilizes a silica-membrane-based technology to efficiently capture and purify DNA, which can then be used for various downstream applications.
Sourced in Germany, United States, Netherlands, Japan, Spain, France, China
The QIAamp MinElute Virus Spin Kit is a laboratory equipment product designed for the purification of viral nucleic acids. It utilizes a silica-membrane-based technology to efficiently extract and concentrate viral DNA or RNA from various sample types.
Sourced in France, United States, Germany, Netherlands, Canada, Switzerland, United Kingdom, Italy
The NucliSENS easyMAG is a laboratory instrument designed for the automated extraction and purification of nucleic acids, including DNA and RNA, from a variety of sample types. It utilizes magnetic bead-based technology to efficiently isolate and concentrate the target molecules for downstream analysis.
Sourced in Panama
Bovi-Shield Gold 5 is a vaccine designed for the prevention of respiratory and reproductive diseases in cattle. It contains inactivated antigens from five different viral pathogens.
Sourced in United States, United Kingdom
BinaxNOW is a rapid, antigen test that detects the presence of the SARS-CoV-2 virus, which causes COVID-19. The test provides results in 15 minutes and can be performed without special equipment or laboratory settings.
Sourced in United States
The HVJ (VR-105 parainfluenza Sendai/52 Z strain) is a virus strain that belongs to the Paramyxoviridae family. It is a widely used laboratory tool for research purposes.
Sourced in United States, Germany
The AgPath-ID One-Step RT-PCR Kit is a laboratory equipment product designed for reverse transcription and amplification of RNA targets in a single reaction. It is suitable for use in real-time PCR applications.
Sourced in France, United States, Netherlands, Germany, United Kingdom
The NucliSENS easyMAG system is a nucleic acid extraction instrument designed for automated, high-throughput sample preparation. It utilizes magnetic silica technology to extract and purify DNA and RNA from a variety of sample types.

More about "Parainfluenza"

Parainfluenza, a group of respiratory viruses, is a leading cause of respiratory illness, especially in young children.
These viruses, part of the Paramyxoviridae family, can infect the upper and lower respiratory tracts, triggering a range of symptoms like cough, congestion, and fever.
In some cases, more severe conditions like pneumonia or croup may develop.
Accurate identification and optimal research protocols are crucial for advancing studies on Parainfluenza and developing effective treatments.
PubCompare.ai, an AI-powered tool, can help locate the best Parainfluenza research protocols from literature, preprints, and patents, ensuring reproducible and accurate findings to support your studies.
Parainfluenza viruses can be detected using various diagnostic kits, such as the QIAamp Viral RNA Mini Kit, Anyplex II RV16 Detection Kit, and QIAamp DNA Mini Kit.
The QIAamp MinElute Virus Spin Kit, NucliSENS easyMAG, and AgPath-ID One-Step RT-PCR Kit are also used for viral RNA extraction and detection.
For animal studies, the Bovi-Shield Gold 5 vaccine can be used to protect against Parainfluenza virus (type 3).
The BinaxNOW rapid antigen test can also be utilized for quick diagnosis.
Additionally, the HVJ (VR-105 parainfluenza Sendai/52 Z strain) is a commonly used virus strain in Parainfluenza research.
By leveraging the insights and tools provided by PubCompare.ai, researchers can optimize their Parainfluenza studies, leading to more reproducible and accurate findings that advance our understanding of this important respiratory virus and support the development of effective treatments.